---
schema_version: "secwatch.filing_event.v1"
accession: "0001528287-23-000033"
form_type: "8-K"
ticker: "NPCE"
cik: "0001528287"
company_name: "NeuroPace Inc"
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T01:45:01.993863+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NeuroPace Q2 revenue $16.5M (+62% YoY); raises FY 2023 guidance to $59-61M

## Summary
- Q2 revenue $16.5M, up 62% YoY and 14% QoQ; net loss narrowed to $9.1M from $12.7M YoY.
- Full-year 2023 revenue guidance raised to $59-61M (30-34% growth), from prior $52-54M.
- Cash burn reduced to $4M in Q2 from $9.8M in Q1; cash and investments $63.6M at June 30.
- NAUTILUS trial enrollment on track; full enrollment expected Q1 2024 for generalized epilepsy.
- Gross margin 72.5%; operating expenses flat YoY; DIXI product distribution contributed to revenue.

## SEC filing metadata
- accession: 0001528287-23-000033
- form_type: 8-K
- ticker: NPCE
- cik: 0001528287
- company_name: NeuroPace Inc
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000033/0001528287-23-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000033/npce-20230808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001528287-23-000033
- JSON: https://secwatch.observer/filing/0001528287-23-000033.json
- Plain text: https://secwatch.observer/filing/0001528287-23-000033.txt

## Key facts
- Earnings Releases
  NeuroPace Inc reported full year 2023 results: revenue $59 million to $61 million. Guidance raised.
  - Period: full year 2023
  - Revenue: $59 million to $61 million
  - Guidance: raised
  - Result: guidance update
  source text: Increased total revenue guidance to range between $59 million and $61 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000033/0001528287-23-000033-index.htm
- Earnings Releases
  NeuroPace Inc reported the second quarter ended June 30, 2023 results: revenue $16.5 million, net income $9.1 million.
  - Period: the second quarter ended June 30, 2023
  - Revenue: $16.5 million
  - Net income: $9.1 million
  - Result: reported results
  source text: Total revenue was $16.5 million in the second quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528287/000152828723000033/0001528287-23-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.